EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

In chronic spontaneous urticaria, increased Galectin‐9 expression on basophils and eosinophils is linked to high disease activity, endotype‐specific markers, and response to omalizumab treatment

Jiang Ji, Minhui Tang, Yue Zhao, Chuqiao Zhang, Yu Shen, Bin Zhou, Cuiping Liu, Marcus Maurer iD, Qingqing Jiao iD

Allergy · 2024

DOI: 10.1111/all.16239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, 2024. Verfasst von Jiang Ji und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Anti-Allergic Agents, Basophils, Biomarkers, Chronic Urticaria. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Galectin‐9 (Gal‐9) has been implicated in allergic and autoimmune diseases, but its role and relevance in chronic spontaneous urticaria (CSU) are unclear.

Objectives

To characterize the role and relevance of Gal‐9 in the pathogenesis of CSU.

Methods

We assessed 60 CSU patients for their expression of Gal‐9 on circulating eosinophils and basophils as well as T cell expression of the Gal‐9 receptor TIM‐3, compared them with 26 healthy controls (HCs), and explored possible links with disease features including disease activity (urticaria activity score, UAS), total IgE, basophil activation test (BAT), and response to omalizumab treatment. We also investigated potential drivers of Gal‐9 expression by eosinophils and basophils.

Results

Our CSU patients had markedly increased rates of circulating Gal‐9 + eosinophils and basophils and high numbers of lesional Gal‐9 + cells. High rates of blood Gal‐9 + eosinophils/basophils were linked to high disease activity, IgE levels, and BAT negativity. Serum levels of TNF‐α were positively correlated with circulating Gal‐9 + eosinophils/basophils, and TNF‐α markedly upregulated Gal‐9 on eosinophils. CSU patients who responded to omalizumab treatment had more Gal‐9 + eosinophils/basophils than non‐responders, and omalizumab reduced blood levels of Gal‐9 + eosinophils/basophils in responders. Gal‐9 + eosinophils/basophils were negatively correlated with TIM‐3 + T H 17 cells.

Conclusion

Our findings demonstrate a previously unrecognized involvement of the Gal‐9/TIM‐3 pathway in the pathogenesis CSU and call for studies that explore its relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Allergic AgentsBasophilsBiomarkersChronic UrticariaEosinophilsGalectinsOmalizumabAdultFemaleHumansMaleMiddle AgedYoung AdultCase-Control StudiesHepatitis A Virus Cellular Receptor 2Severity of Illness IndexTreatment Outcome

Stichwörter der Autor:innen

Galectin‐9 (Gal‐9)T cell immunoglobulin‐ and mucin‐domain‐containing molecules‐3 (TIM‐3)TH1 cellsTH17 cellsTNF‐αangioedemabasophilschronic spontaneous urticariaeosinophilsmast cellsp38 MAPKwheals

Substanzen

Anti-Allergic AgentsBiomarkersGalectinsHAVCR2 protein, humanHepatitis A Virus Cellular Receptor 2LGALS9 protein, humanOmalizumab

Autor:innen und Institutionen

  • Department of Dermatology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Dermatology, The Second Affiliated Hospital of Soochow University, Su Zhou, China.
  • Department of Dermatology, The First Affiliated Hospital of Hainan Medical University, Haikou, China.
  • Suzhou Kowloon hospital, Shanghai Jiaotong University School of Medicine, Suzhou, China.
  • Jiangsu Institute of Clinical Immunology & Jiangsu Key Laboratory of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

ORCID-Profile: Marcus Maurer, Qingqing Jiao

Zitieren

APA

Ji, J., Tang, M., Zhao, Y., Zhang, C., Shen, Y., Zhou, B., Liu, C., Maurer, M., & Jiao, Q. (2024). In chronic spontaneous urticaria, increased Galectin‐9 expression on basophils and eosinophils is linked to high disease activity, endotype‐specific markers, and response to omalizumab treatment. Allergy. https://doi.org/10.1111/all.16239

Vancouver

Ji J, Tang M, Zhao Y, Zhang C, Shen Y, Zhou B, et al. In chronic spontaneous urticaria, increased Galectin‐9 expression on basophils and eosinophils is linked to high disease activity, endotype‐specific markers, and response to omalizumab treatment. Allergy. 2024. doi:10.1111/all.16239

BibTeX
@article{Ji2024,
  author = {Ji, Jiang and Tang, Minhui and Zhao, Yue and Zhang, Chuqiao and Shen, Yu and Zhou, Bin and Liu, Cuiping and Maurer, Marcus and Jiao, Qingqing},
  title = {In chronic spontaneous urticaria, increased Galectin‐9 expression on basophils and eosinophils is linked to high disease activity, endotype‐specific markers, and response to omalizumab treatment},
  journal = {Allergy},
  year = {2024},
  doi = {10.1111/all.16239}
}
Kostenlos starten →